Exosomes and Atherogenesis
- PMID: 34513963
- PMCID: PMC8427277
- DOI: 10.3389/fcvm.2021.738031
Exosomes and Atherogenesis
Abstract
Myocardial infarction and ischemic stroke are the leading causes of mortality worldwide. Atherosclerosis is their common pathological foundation. It is known that atherosclerosis is characterized by endothelial activation/injury, accumulation of inflammatory immune cells and lipid-rich foam cells, followed by the development of atherosclerotic plaque. Either from arterial vessel wall or blood circulation, endothelial cells, smooth muscle cells, macrophages, T-lymphocytes, B-lymphocytes, foam cells, and platelets have been considered to contribute to the pathogenesis of atherosclerosis. Exosomes, as natural nano-carriers and intercellular messengers, play a significant role in modulation of cell-to-cell communication. Under physiological or pathological conditions, exosomes can deliver their cargos including donor cell-specific proteins, lipids, and nucleic acids to target cells, which in turn affect the function of the target cells. In this review, we will describe the pathophysiological significance of various exosomes derived from different cell types associated with atherosclerosis, and the potential applications of exosome in clinical diagnosis and treatment.
Keywords: atherosclerosis; exosome; immunocyte; inflammation; vascular injury.
Copyright © 2021 Lin, Yang, Song, Dang and Feng.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Exosomes: Multifaceted Messengers in Atherosclerosis.Curr Atheroscler Rep. 2020 Aug 9;22(10):57. doi: 10.1007/s11883-020-00871-7. Curr Atheroscler Rep. 2020. PMID: 32772195 Review.
-
Exosomes in Cholesterol Metabolism and Atherosclerosis.Cardiovasc Hematol Disord Drug Targets. 2017;17(3):185-194. doi: 10.2174/1871529X18666180103124443. Cardiovasc Hematol Disord Drug Targets. 2017. PMID: 29299993 Review.
-
CD40 signaling in vascular cells: a key role in atherosclerosis?Atherosclerosis. 1998 Apr;137 Suppl:S89-95. doi: 10.1016/s0021-9150(97)00309-2. Atherosclerosis. 1998. PMID: 9694547 Review.
-
Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation.Theranostics. 2019 Sep 21;9(23):6901-6919. doi: 10.7150/thno.37357. eCollection 2019. Theranostics. 2019. PMID: 31660076 Free PMC article.
-
Exosomes: An emerging factor in atherosclerosis.Biomed Pharmacother. 2019 Jul;115:108951. doi: 10.1016/j.biopha.2019.108951. Epub 2019 May 8. Biomed Pharmacother. 2019. PMID: 31078042 Review.
Cited by
-
Macrophage-derived exosomal miR-4532 promotes endothelial cells injury by targeting SP1 and NF-κB P65 signalling activation.J Cell Mol Med. 2022 Oct;26(20):5165-5180. doi: 10.1111/jcmm.17541. Epub 2022 Sep 7. J Cell Mol Med. 2022. PMID: 36071548 Free PMC article.
-
miR-186-5p Dysregulation in Serum Exosomes from Patients with AMI Aggravates Atherosclerosis via Targeting LOX-1.Int J Nanomedicine. 2022 Dec 13;17:6301-6316. doi: 10.2147/IJN.S383904. eCollection 2022. Int J Nanomedicine. 2022. PMID: 36536941 Free PMC article.
-
The Role of Macrophages in Atherosclerosis: Participants and Therapists.Cardiovasc Drugs Ther. 2025 Apr;39(2):459-472. doi: 10.1007/s10557-023-07513-5. Epub 2023 Oct 21. Cardiovasc Drugs Ther. 2025. PMID: 37864633 Review.
-
Engineered exosomes: a promising drug delivery platform with therapeutic potential.Front Mol Biosci. 2025 May 9;12:1583992. doi: 10.3389/fmolb.2025.1583992. eCollection 2025. Front Mol Biosci. 2025. PMID: 40417062 Free PMC article. Review.
-
Research progress of extracellular vesicles and exosomes derived from mesenchymal stem cells in the treatment of oxidative stress-related diseases.Front Immunol. 2023 Aug 14;14:1238789. doi: 10.3389/fimmu.2023.1238789. eCollection 2023. Front Immunol. 2023. PMID: 37646039 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources